... 2018. If approved on its own, patients would have to take it daily to maintain protection. Regeneron, based in Tarrytown, New York, gained approval in March for Dupixent to treat a severe form of the skin condition eczema. Dupixent, developed in ...
http://ift.tt/2ztdScU
No comments:
Post a Comment